Market Report -- In Play ()

MSN Money - USA
Gapping Up ACOR +161% (announces positive results of Phase 3 Study of Fampridine-SR on walking in people with multiple sclerosis), WARR +72.% (being acquired ...

StreetInsider.com Pre-Open Movers 09/25
StreetInsider.com (subscription) - Birmingham,MI,USA
(Nasdaq: ACOR) 154% HIGHER; announced positive results from its Phase 3 clinical trial of Fampridine-SR on walking in people with multiple sclerosis (MS). ...

Acorda Releases Positive Fampridine Data
MSN Money - USA
... The company said that significantly more people with MS improved their walking speed when taking Fampridine-SR compared with those taking placebo. ...
See all stories on this topic

---

Fampridine-acorda

Monday's Health Winners & Losers
TheStreet.com - USA
Acorda Therapeutics (ACOR - commentary - Cramer's Take) saw its shares soar after the ... a late-stage clinical trial of its multiple sclerosis drug Fampridine-SR. ...
See all stories on this topic

09/25 StreetInsider.com Unusual 11 Mid-Day Movers
StreetInsider.com (subscription) - Birmingham,MI,USA
Acorda Therapeutics, Inc. (Nasdaq: ACOR) 234% HIGHER; Announced positive results from its Phase 3 clinical trial of Fampridine-SR on walking in people with ...

StreetInsider.com After-Hours Movers 09/25
StreetInsider.com (subscription) - Birmingham,MI,USA
... Acorda Therapeutics, Inc ... ACOR) 4.7% HIGHER; continues today's 283% run-up after announcing positive results from its Phase 3 clinical trial of Fampridine-SR on ...

The Dow Gained 68 Points, Nasdaq Added 30
StreetInsider.com (subscription) - Birmingham,MI,USA
... stories, Acorda Therapeutics, Inc. (Nasdaq: ACOR) gained 283% today after announcing positive results from its Phase 3 clinical trial of Fampridine-SR on ...